Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Intestinal epithelial cell death as modulator of intestinal dysbiosis, systemic autoimmunity and the onset of arthritis (FOR 2886 A2) FOR 2886: PANDORA - Pathways triggering AutoimmuNity and Defining Onset of early Rheumatoid Arthritis July 1, 2018 - Dec. 31, 2025 Empathokinästhetische Messung und Bewegungsmustererkennung als Biomarker für Gesundheitszustand (SFB 1483 EmpkinS D05) Empatho-Kinaesthetic Sensor Technology (SFB 1483 EmpkinS) July 1, 2021 - Dec. 31, 2025 P165-OA: Lipid nanoparticles for targeted delivery of HIV-1 antigens and genetic immunomodulators Jan. 1, 2025 - Dec. 31, 2025 P154-OA: Establishing an in vitro negative-pressure wound therapy (NPWT) model and analysing molecular effects of NPWT Jan. 1, 2025 - Dec. 31, 2025 IZKF-S2 Tame the Flame (M3): Interplay of cell trafficking and mechanics as a pathomechanism in immune-mediated inflammation “TAME THE FLAME” Jan. 1, 2024 - Dec. 31, 2025 IZKF-S1 Train (Physiologie): TRAIN: Towards Rationalizing Neurodevelopment Jan. 1, 2024 - Dec. 31, 2025 Non-invasive prenatal diagnosis (NIPD) of XLHED: Cell-free fetal DNA analysis to identify pathogenic EDA variants (KI-SIM_NIPD of XLHED) Jan. 1, 2024 - Dec. 31, 2025 P163-OA: Digital mobility outcomes in Parkinson’s disease derived by sensor technology in real-life Jan. 1, 2025 - Dec. 31, 2025 P158: CSF1R-interactome analysis to identify signaling modulators in HDLS Jan. 1, 2025 - Dec. 31, 2025 P136: Deciphering the effects of tyrosine kinase inhibitor therapy on bone metabolism and longitudinal growth Jan. 1, 2025 - Dec. 31, 2025